CMAX Clinical Research, a world-renowned leader in its field, has announced its 30th anniversary of dedicated service in advancing medical knowledge and enhancing healthcare through ground-breaking clinical trials for local and international companies.
Since its inception in 1993, CMAX has been at the forefront of conducting an extensive range of early-phase research across various therapeutic areas including neuroscience, pain management, infectious diseases, and beyond. With an unwavering commitment to safety, efficacy, and participant well-being, CMAX has successfully contributed to the development and approval of numerous life-changing treatments.
As a result, CMAX has established itself as a trusted and respected partner in the pharmaceutical and biotechnology industries. The organisation’s experienced team of over 300, physicians, nurses and qualified support staff have consistently demonstrated unwavering dedication to ensure that every clinical trial is conducted with the highest standards of quality and integrity.
Jane Kelly, CEO of CMAX says they are incredibly proud to celebrate three decades of accomplishments, innovation, and collaboration and the global impact we have been able to create.
“This milestone is a testament to the hard work and commitment of not only our entire team, but also the invaluable contributions of the thousands of our participants over the years. Together, we have made significant strides in advancing medical knowledge and improving patient care.”
By participating in clinical trials at CMAX, South Australians have not only contributed to the advancement of medicine but have also received exceptional care in a supportive and compassionate environment.
Looking ahead, CMAX is dedicated to continuing its mission of transforming lives through medical research. The organisation will continue to pioneer new studies, explore emerging therapies, and collaborate with industry partners to develop innovative treatment options for patients in need.
To learn more about CMAX Clinical Research and its ongoing clinical trials, please visit www.cmax.com.au or contact the team on 1800 150 433.
